Daniel Chui

Daniel Chui serves as the US Digital Transformation & Inorganic Growth Lead at Haleon since 2022, focusing on innovative healthcare product development and M&A opportunity assessments. Previously, Daniel was Director of External Innovation at GSK from 2017 to 2022, concentrating on digital consumer healthcare innovations. Daniel's earlier experience includes a role as Principal at Verizon Ventures (2013-2017), where investment opportunities and strategic integration were prioritized, as well as a brief tenure in strategic partnerships at Verizon Wireless. Daniel’s career began at Alcatel-Lucent (2004-2012) as Business Development Director, overseeing emerging technologies and ecosystem development. Additional roles included analyst positions at Datamonitor Inc. and consultative projects for HSBC and Lucent Technologies. Daniel holds an MBA from London Business School and a B.S. in Chemical Engineering from the University of Michigan.